Chat with us
Research Assistance
Online
  • Please enter your first name.

Asia Pacific Infectious Disease Molecular Diagnostics Market Size & Outlook

The infectious disease molecular diagnostics market in Asia Pacific is expected to reach a projected revenue of US$ 5,312.4 million by 2030. A compound annual growth rate of 5.2% is expected of Asia Pacific infectious disease molecular diagnostics market from 2025 to 2030.

  • Clinical Diagnostics
    • In Vitro Diagnostics
      • Infectious Disease Molecular Diagnostics Market Outlook
Revenue, 2024 (US$M)
$3,916.0
Forecast, 2030 (US$M)
$5,312.4
CAGR, 2025 - 2030
5.2%
Report Coverage
Asia Pacific

Asia Pacific Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)

Asia Pacific Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Global Market

Related Markets

Prism AI by Grand View ResearchFree to try

Ask a question about the infectious disease molecular diagnostics market

Every figure cited from GVR research

Asia Pacific infectious disease molecular diagnostics market highlights

  • The Asia Pacific infectious disease molecular diagnostics market generated a revenue of USD 3,916.0 million in 2024.
  • The market is expected to grow at a CAGR of 5.2% from 2025 to 2030.
  • In terms of segment, reagents product was the largest revenue generating product in 2024.
  • Others Product is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.

Asia Pacific data book summary

Market revenue in 2024USD 3,916.0 million
Market revenue in 2030USD 5,312.4 million
Growth rate5.2% (CAGR from 2025 to 2030)
Largest segmentReagents product
Fastest growing segmentOthers Product
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments Product, Reagents Product, Others Product
Key market players worldwideAbbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 24.6% of the global infectious disease molecular diagnostics market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Latin America is the fastest growing regional market and is projected to reach USD 1,034.5 million by 2030.

Increase in prohealth initiatives, adoption of better technologies, and rise in consumer awareness are driving growth in this region. In addition, rising prevalence of infectious diseases, increasing demand for cost-effective treatment, and growing target population are factors contributing to market growth. 

Asia Pacific markets such as China, Australia, Korea, and Taiwan already have a healthcare reimbursement system that provides inclusive coverage for molecular diagnostic tests. Significantly high untapped opportunities in the form of unmet medical needs and increase in initiatives for scientific research are some primary growth drivers. 

Moreover, improving healthcare regulatory scenario in the high-growth countries is expected to attract international players to invest and capitalize on the available opportunities. Positive changes, such as healthcare benefits being provided by governments, increased awareness among the population, and urge to avail high-end medical treatment are also expected to drive regional market growth.

No credit card required*

Publish Date: Mar 04, 2025

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Infectious Disease Molecular Diagnostics Market Companies

NameProfile# EmployeesHQWebsite
Roche Holding AG ADRView profile 103,605Grenzacherstrasse 124, Basel, Switzerland, 4070www.roche.com
Abbott LaboratoriesView profile 114,000100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400www.abbottinvestor.com
Becton Dickinson & CoView profile 73,0001 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880www.bd.com
BioMerieux SAView profile 13,982Marcy l’Etoile, Lyon, France, 69280www.biomerieux.com
Siemens Healthineers AG ADRView profile 71,400Siemensstr. 3, Forchheim, BY, Germany, 91301www.siemens-healthineers.com
Danaher CorpView profile 63,0002200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701www.danaher.com
Illumina IncView profile 9,3005200 Illumina Way, San Diego, CA, United States, 92122www.illumina.com
Agilent Technologies IncView profile 17,7005301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051www.agilent.com
Bio-Rad Laboratories IncView profile 8,0301000 Alfred Nobel Drive, Hercules, CA, United States, 94547www.bio-rad.com
Qiagen NVView profile 5,900Hulsterweg 82, Venlo, LI, Netherlands, 5912 PLwww.qiagen.com

Asia Pacific Infectious Disease Molecular Diagnostics Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Infectious Disease Molecular Diagnostics Market Outlook will help companies and investors design strategic landscapes.


Reagents Product was the largest segment with a revenue share of 67.75% in 2024.

Horizon Databook has segmented the Asia Pacific infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.




Increase in prohealth initiatives, adoption of better technologies, and rise in consumer awareness are driving growth in this region. In addition, rising prevalence of infectious diseases, increasing demand for cost-effective treatment, and growing target population are factors contributing to market growth. 

Asia Pacific markets such as China, Australia, Korea, and Taiwan already have a healthcare reimbursement system that provides inclusive coverage for molecular diagnostic tests. Significantly high untapped opportunities in the form of unmet medical needs and increase in initiatives for scientific research are some primary growth drivers. 

Moreover, improving healthcare regulatory scenario in the high-growth countries is expected to attract international players to invest and capitalize on the available opportunities. Positive changes, such as healthcare benefits being provided by governments, increased awareness among the population, and urge to avail high-end medical treatment are also expected to drive regional market growth.

  • Asia Pacific Infectious Disease Molecular Diagnostics Market Product Outlook (Revenue, USD Million , 2018-2030)
    • Instruments Product
    • Reagents Product
    • Services Product
  • Asia Pacific Infectious Disease Molecular Diagnostics Market Test location Outlook (Revenue, USD Million , 2018-2030)
    • Hospitals
    • Clinics
    • Diagnostics Laboratories
    • Research Institutes
  • Asia Pacific Infectious Disease Molecular Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
    • Polymerase Chain Reaction (PCR)
    • In Situ Hybridization
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and microarrays
    • Mass spectrometry
    • Transcription Mediated Amplification
    • Others
  • Asia Pacific Infectious Disease Molecular Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
    • Respiratory Diseases
    • Tuberculosis
    • Meningitis
    • Gastrointestinal Tract Infections
    • HPV
    • Sexually Transmitted Infection
    • Sepsis
    • Drug Resistance Disease
    • Others Application

Reasons to subscribe to Infectious Disease Molecular Diagnostics Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Infectious Disease Molecular Diagnostics Market Outlook databook

  • Our clientele includes a mix of Infectious Disease Molecular Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Infectious Disease Molecular Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Infectious Disease Molecular Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Asia Pacific Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)

No Access Stack Chart

Asia Pacific infectious disease molecular diagnostics market statistics, by product, 2018-2030 (US$M)

No Access Pie Chart

Asia Pacific infectious disease molecular diagnostics market statistics, by country, 2018-2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more